Oversight in your inbox
Weekly newsletter and updates
Latest Policy Publications
POGO’s experts push policymakers to enact commonsense reforms that tackle waste, corruption, and abuse of power; hold those who’ve violated the public trust accountable; protect our constitutional rights; and make the government work for all people.
-
Analysis
FDA Set Low Bar for Approval of Blood Thinners
The Project On Government Oversight’s past reporting on prescription blood thinners illustrates how low the FDA has set the bar for drug approval and what the FDA has glossed over or overlooked along the way.
-
Analysis
POGO Testifies about Costs of Overclassification and Government Secrecy
POGO’s Scott Amey testified this week before the House Committee on Oversight and Government Reform at a hearing titled “Examining the Costs of Overclassification on Transparency and Security.” POGO’s testimony highlighted ways the executive branch conceals information from Co...
-
Policy Letter
POGO and Bipartisan Ethics Experts in New Letter to Trump: Divest Now to Prevent Ongoing Conflicts
A group of bipartisan experts urge President-elect Donald Trump to immediately divest his businesses and place the assets and investments into a genuine blind trust.
-
Analysis
POTUS Can’t Overlook Pitfalls of 21st Century Cures Act
The 21st Century Cures Act just passed by Congress greatly deregulates the drug approval process, to the detriment of patients and anyone who will be paying for health care.
-
Testimony
Testimony of Scott Amey about the Burdens of Overclassification and Government Secrecy
POGO's Scott Amey testified before the House Committee on Oversight and Government Reform at a hearing titled “Examining the Costs of Overclassification on Transparency and Security”. POGO's testimony highlighted ways the executive branch conceals information from Congress and...
-
Analysis
New Roadblock for Inspectors General Access to Information
Last minute concerns over the IG Empowerment Act of 2015 may delay necessary legislation until next Congress.
-
Analysis
FDA and Patient Groups Are Addicted to Drug Industry
A new investigation by the Project On Government Oversight (POGO) reveals the extent to which the FDA is dependent upon the pharmaceutical industry for its funding. And many of the so-called patient and consumer advocacy groups that are supposed to be a bulwark against industr...
-
AnalysisNDAA Conferees Drop Harmful Secrecy Language from Final Bill
The National Defense Authorization Act for Fiscal Year 2017 no longer contains a provision that would strip the public of its ability to obtain information regarding Pentagon operations under the Freedom of Information Act.
-
AnalysisDefense Policy Bill Expands Protections for Military Whistleblowers
The National Defense Authorization act for Fiscal Year 2017 includes a number of provisions to greatly enhance protections for military whistleblowers.
-
Analysis
New Rule: Even the Appearance of a Conflict of Interest Should Be Avoided for Government Employees
The Office of Government Ethics finalized a rule governing the solicitation and acceptance of gifts to government employees from outside sources. The new rule is intended to “advance public confidence in the integrity of Federal officials” by advising government employees that...
-
Analysis
House Oversight Committee Takes Aim at Improper Payments
The House Oversight and Government Reform Committee released a report detailing ineffectiveness of current improper payment system.
-
Policy Letter
Groups Urge President-Elect Trump to Place his Business Assets and Investments into a Genuine Blind Trust
The Project On Government Oversight (POGO) today joined more than a dozen ethics officials and good government groups to send a letter to President-Elect Donald Trump urging him to set up a genuine blind trust, or the equivalent, for all of his business assets and investments.